Drugs controlling proteinuria of patients with Alport syndrome

World Journal of Pediatrics

Volumn 5, Issue 4, 2009, Pages 308-311

  Li, Jian Guo ^a   Ding, Jie ^a   Wang, Fang ^a   Zhang, Hong Wen ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Alport syndrome; Angiotensin converting enzyme inhibitor; Herbal medicine; Tripterygium

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; HERBACEOUS AGENT;

ALPORT SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEMATURIA; HUMAN; KIDNEY DISEASE; LEUKOCYTE COUNT; MALE; MENSTRUAL IRREGULARITY; PROTEINURIA; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; TRIPTERYGIUM;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; NEPHRITIS, HEREDITARY; PHYTOTHERAPY; PROTEINURIA; TRIPTERYGIUM;

EID: 73349119125     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-009-0059-5     Document Type: Article

References (19)

1. C.E. Kashtan 1998 Alport syndrome and thin glomerular basement membrane disease J Am Soc Nephrol 9 1736 1750 1:STN:280:DyaK1czpsVeltA%3D%3D 9727383
2. C. Burton K.P. Harris 1996 The role of proteinuria in the progression of chronic renal failure Am J Kidney Dis 27 765 775 10.1016/S0272-6386(96)90512-0 1:STN:280:DyaK283jtl2ntQ%3D%3D 8651239
3. W. Proesmans H. Knockaert D. Trouet 2000 Enalapril in paediatric patients with Alport syndrome: 2 years' experience Eur J Pediatr 159 430 433 10.1007/s004310051301 1:CAS:528:DC%2BD3cXkvFWktrc%3D 10867848
4. E.P. Cohen J. Lemann Jr. 1996 In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression Am J Kidney Dis 27 199 203 10.1016/S0272-6386(96)90540-5 1:CAS:528:DyaK28Xhs1Shsb4%3D 8659493
5. W. Proesmans M. Van Dyck 2004 Enalapril in children with Alport syndrome Pediatr Nephrol 19 271 275 10.1007/s00467-003-1366-z 14745635 (Pubitemid 38313009)
6. O. Gross B. Beirowski M.L. Koepke J. Kuck M. Reiner K. Addicks, et al. 2003 Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome Kidney Int 63 438 446 10.1046/j.1523-1755.2003.00779.x 1:CAS:528:DC%2BD3sXht1yrs7w%3D 12631109 (Pubitemid 36126790)
7. H. Kaito K. Nozu K. Iijima K. Nakanishi K. Yoshiya K. Kanda, et al. 2006 The effect of aldosterone blockade in patients with Alport syndrome Pediatr Nephrol 21 1824 1829 10.1007/s00467-006-0270-8 17039334 (Pubitemid 44741159)
8. M. Charbit M.C. Gubler M. Dechaux M.F. Gagnadoux J.P. Grünfeld P. Niaudet 2007 Cyclosporin therapy in patients with Alport syndrome Pediatr Nephrol 22 57 63 10.1007/s00467-006-0227-y 17024394 (Pubitemid 46138361)
9. T.S. Sigmundsson R. Palsson S. Hardarson V. Edvardsson 2006 Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine Scand J Urol Nephrol 40 522 525 10.1080/00365590600830417 17130107 (Pubitemid 44847036)
10. W. Proesmans I.V. Wambeke M.V. Dyck 1996 Long-term therapy with enalapril in patients with nephrotic-range proteinuria Pediatr Nephrol 10 587 589 10.1007/s004670050166 1:STN:280:DyaK2s%2Flt12gsA%3D%3D 8897561 (Pubitemid 26331768)
11. J.P. Jais B. Knebelmann I. Giatras M. De Marchi G. Rizzoni A. Renieri, et al. 2000 X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males J Am Soc Nephrol 11 649 657 1:CAS:528:DC%2BD3cXisFert7Y%3D 10752524
12. L. Callís A. Vila M. Carrera J. Nieto 1999 Long-term effects of cyclosporine A in Alport's syndrome Kidney Int 55 1051 1056 10.1046/j.1523-1755. 1999.0550031051.x 10027943 (Pubitemid 29100718)
13. D. Chen B. Jefferson S.J. Harvey K. Zheng C.J. Gartley R.M. Jacobs, et al. 2003 Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model J Am Soc Nephrol 14 690 698 10.1097/01.ASN.0000046964.15831.16 1:CAS:528:DC%2BD3sXht1Kjtr8%3D 12595505 (Pubitemid 36246013)
14. G. Lama I. Luongo A. Piscitelli M.E. Salsano 2000 Enalapril: antiproteinuric effect in children with nephrotic syndrome Clin Nephrol 53 432 436 1:CAS:528:DC%2BD3MXhtl2gsrw%3D 10879662
15. L. Adler R. Mathew S. Futterweit R. Frank B.G. Gauthier C.E. Kashtan, et al. 2002 Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion BMC Nephrol 3 2 10.1186/1471-2369-3-2 11869456
16. X. Jiang 1994 Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome Pediatr Nephrol 8 343 344 10.1007/BF00866356 1:STN:280:DyaK2M%2FgtFaqtQ%3D%3D 7917863 (Pubitemid 24162277)
17. C.X. Zheng Z.H. Chen C.H. Zeng W.S. Qin L.S. Li Z.H. Liu 2008 Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro Kidney Int 74 596 612 10.1038/ki.2008.203 1:CAS:528:DC%2BD1cXpvVaiur8%3D 18509322
18. M. Sharma J.Z. Li R. Sharma M. Artero X. Ge E.T. McCarthy, et al. 1997 Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro Nephrol Dial Transplant 12 2064 2068 10.1093/ndt/12.10.2064 1:CAS:528:DyaK2sXntFCisrk%3D 9351066 (Pubitemid 27423242)
19. Y.G. Wan W. Sun Y. Wang J. Zhang M. Li J.G. Ruan, et al. 2006 Effects of multi-glycoside of Tripterygium wilfordii Hook. f. on proteinuria and expression of slit diaphragm-associated molecules in rats with anti-thy1.1 glomerulonephritis Zhong Guo Zhong Xi Yi Jie He Za Zhi 26 1094 1102 1:CAS:528:DC%2BD2sXhtFajsr3O